All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Systematic Review Finds GLP-1 Agonists Do Not Harm Male Fertility, May Offer Benefits

By

Miriam E. Tucker

4h ago· 4 min readenNews

Summary

A systematic review presented at a medical conference found that GLP-1 agonists (like Ozempic, Wegovy) do not harm male fertility or the male reproductive axis. The review, which analyzed three randomized controlled trials, found no negative long-term effects on the hypothalamic-pituitary-gonadal axis and some evidence suggesting potential fertility benefits. Study author Dr. Pratibha Natesh noted the data is still sparse but sufficient to counsel patients that these drugs don't negatively impact the reproductive system.

Source

Twitter / XSystematic Review Finds GLP-1 Agonists Do Not Harm Male Fertility, May Offer Benefitsmdsc.pe

Key quotes

· 3 pulled
One thing we proved is that they do not harm the reproductive axis in men. There was no inhibitory effect, so we can counsel our patients that the drugs don't impact the reproductive system negatively.
We only found three randomized control
Current evidence does not show a negative long-term effect of GLP-1 agonists on male fertility, and some data suggest the drugs may offer benefits
Snippet from the RSS feed
A systematic review finds no consistent adverse effects on the male hypothalamic-pituitary-gonadal axis and some evidence of fertility improvement with GLP-1 use.

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.